HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous System by Eduardo Samo Gudo et al.
Gudo et al. Virology Journal  (2015) 12:165 
DOI 10.1186/s12985-015-0398-xRESEARCH Open AccessHAM/TSP-derived HTLV-1-infected T cell
lines promote morphological and functional
changes in human astrocytes cell lines:
possible role in the enhanced T cells
recruitment into Central Nervous System
Eduardo Samo Gudo1,2*, Suse Dayse Silva-Barbosa3, Leandra Linhares-Lacerda2, Marcelo Ribeiro-Alves2,
Suzana Corte Real4, Dumith Chequer Bou-Habib2 and Wilson Savino2Abstract
Background: The mechanisms through which HTLV-1 leads to and maintains damage in the central nervous system of
patients undergoing HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) are still poorly understood. In
recent years, increasing evidence indicates that, not only lymphocytes but also glial cells, in particular astrocytes, play a
role in the pathophysiology of HAM/TSP. In this study we used a model of co-culture between human HTLV-1-infected
(CIB and C91PL) and non-infected (CEM) T lymphocyte cell lines and astrocyte (U251 and U87) cell lines to mimic the
in vivo T cell-astrocyte interactions.
Results: We first observed that CIB and C91PL adhere strongly to cultured astrocytes cell lines, and that co-cultures of
HTLV-1 infected and astrocyte cell lines cells resulted in rapid syncytium formation, accompanied by severe
morphological alterations and increased apoptotic cell death of astrocyte cells. Additionally, cultures of astrocyte cell
lines in presence of supernatants harvested from HTLV-1-infected T cell cultures resulted in significant increase in the
mRNA of CCL2, CXCL1, CXCL2, CXCL3, CXCL10, IL-13, IL-8, NFKB1, TLR4, TNF, MMP8 and VCAM1, as compared with the
values obtained when we applied supernatants of non-infected T- cell lines. Lastly, soluble factors secreted by cultured
astrocytic cell lines primed through 1-h interaction with infected T cell lines, further enhanced migratory responses, as
compared to the effect seen when supernatants from astrocytic cell lines were primed with non-infected T cell lines.
Conclusion: Collectively, our results show that HTLV-1 infected T lymphocyte cell lines interact strongly with astrocyte
cell lines, leading to astrocyte damage and increased secretion of attracting cytokines, which in turn may participate in
the further attraction of HTLV-1-infected T cells into central nervous system (CNS), thus amplifying and prolonging the
immune damage of CNS.
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Human T-cell leukemia virus type 1 (HTLV-1) is the etio-
logical agent of HTLV-1-associated myelopathy/tropical
spastic paraparesis (HAM/TSP), a chronic and slowly pro-
gressive neurodegenerative disease of the central nervous
system (CNS) [1, 2] and Adult T-cell leukemia/lymphoma
(ATL) [3]. Worldwide, an estimated 20 million people are
infected with HTLV-1, thus placing this infection as a ser-
ious public health problem. Nevertheless, the majority of
infected individuals remain asymptomatic carriers and less
than 5 % develop HAM/TSP [4–8].
Histopathological findings of CNS revealed that HAM/
TSP affects mostly the lower and middle thoracic spinal
cord, with marked degeneration of the corticospinal tracts
and demyelination, accompanied by diffuse and symmet-
rical degeneration of the anterolateral and inner portion
of the posterior columns [9]. These findings are consistent
with the HAM/TSP patient’s neurological symptoms, in-
cluding spastic paraplegia of the lower extremities, loss of
bladder control, and sexual dysfunction [1, 10–12].
To date, the precise mechanisms by which HTLV-1
promotes these lesions remain poorly understood.
Nevertheless, available data indicate that progression to
HAM/TSP is characterized by presence of an exagger-
ated and chronic immune response [13], accompanied
by massive infiltration of mononuclear cells into the
CNS, hyper secretion of pro-inflammatory cytokines and
chemokines [14] and spontaneous proliferation T lym-
phocytes [13–24]. Although the lesions in the CNS have
been primarily attributed to these infiltrating lympho-
cytes, growing evidence points that glial cells, particu-
larly astrocytes, play a key role in this process [14, 25].
Damage of astrocytes is structurally and functionally
deleterious to the CNS, since these cells exert important
functions, such as: maintenance of the integrity of the
blood–brain barrier (BBB), neural cell survival and con-
trol of brain excitability [26–28]. Histopathological find-
ings from post mortem tissues revealed that astrocytes from
HAM/TSP lesions bear an activated phenotype and pro-
duce high amounts of pro-inflammatory cytokines, matrix
metalloproteinases (MMPs) and chemokines [14, 29, 30].
Additionally, in vitro studies demonstrated that interactions
with HTLV-1-infected lymphocytes resulted in morpho-
logical changes of astrocytes similarly to those found in post
mortem [31, 32], being accompanied by metabolic deregula-
tion [33, 34].
However the participation of astrocytes in the patho-
physiology of HAM/TSP remains poorly understood,
particularly their role in the recruitment and trafficking
of peripheral T cells into CNS. In this context, we con-
ducted a study to investigate the morphological and
functional alterations exerted by HTLV-1-infected T cell
lines upon astrocytoma-derived cell lines. In particular,
we used an in vitro model of T cell-astrocyte cell linesinteraction to approach the potential the impact of HTLV-
1-infected T cell lines in the integrity and gene expressing
profile of migration-related genes of astrocytic cell lines.
We also analyzed the migratory response of HTLV-1-T
lymphocyte cell lines under the stimulation of astro-
cytic cell lines primed with supernatants derived from
HTLV-1+ T cell lines. Our results indicate that under
transient interactions with HTLV-1-infected T cell line
cells, astrocytic cell lines undergo major morphological
changes, together with modulation in the expression of
a variety of cell-migration genes. In turn, such reactive
astrocytic cell lines increase migratory responses of
HTLV-1-infected lymphocytes, thus suggesting a role of
these glial elements in the recruitment of additional T
cells into CNS.Results
Increased adhesion of HTLV-1-infected T lymphocyte cell
lines onto astrocytoma cell lines
In the first set of experiments, we investigated the adhe-
sion of HTLV-1-infected (CIB and C91PL) and non-
infected (CEM) T cell lines to astrocytoma monolayers
(U251). The adhesion assay was performed during 30 min,
after which non-adherent lymphocytes cell lines were
removed and adherent lymphocytes cell lines counted
after Giemsa staining. We found that after 30 min in co-
cultures, the adhesion degree of HTLV-1 infected T cell
lines, (CIB in the Fig. 1b and C91PL in the Fig. 1c) to the
astrocytoma cell lines was significantly higher than that of
uninfected T cell lines, as illustrated by the measurement
of adhesion index of CIB cells (Fig. 1d).Co-culture of HTLV-1-T lymphocyte cell lines with astrocytic
cell lines results in rapid syncytium formation
Since HTLV-1 infected T cell lines adhered strongly to
the astrocytoma monolayers, we investigated the mor-
phological alterations, including syncytium formation
after persistent interaction between these cells. For this
purpose, HTLV-1 infected T cell lines (CIB and C91PL)
were co-cultured with the astrocytoma cell lines (U251
and U87) for up to 20 h, after which, non-adherent cells
were removed and the alterations observed after Giemsa
staining. We observed heterocellular cell fusion, and
syncytium formation between HTLV-1 infected T cell
lines and astrocytoma cell lines as early as 6 h post co-
culture. These changes were equally seen when the CIB
(Fig. 2b, c, f, g) and C91PL (Fig. 2d) HTLV-1 infected
cell lines were added onto the astrocytic monolayer. In
addition, the effect of HTLV-1 infected cell lines on the
astrocytoma cell lines U251 (Fig. 2a–d) and U87
(Fig. 2e–g) was similar. No syncytium could be detected
when CEM cells were co-cultured with either astrocy-
toma monolayer (Fig. 2a, e) or when non astrocytic cell
Fig. 1 Enhanced adhesion of HTLV-1-infected T cell lines onto human astrocytoma cell lines. HTLV-1-infected (CIB and C91PL) or non-infected
(CEM) T cell lines were co-cultured with astrocytoma cell lines (U251) for 30 min. Representative microscopic fields of low magnification indicate
higher adhesion degree of HTLV-1-infected T cell lines (b and c) versus non-infected T cell lines (a). Panel d depicts higher adhesion degree of
HTLV-1-infected T cell lines (CIB and C91PL) as determined by the measurement of adhesion index. Values in panel (d) correspond to mean ± se
of 3 independent experiments for each T cell line. *p < 0.05. Original magnifications: ×200
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T cell lines (Fig. 2i).
Transient contact with HTLV-1-infected cell lines leads to
long-term cytopathic effects on astrocytoma cell lines
In the following set of experiments, we were interested
to investigate the long term impact of HTLV-1 infected
T cells on astrocytes cell lines, including the morpho-
logical and ultra structural alterations and induction of
apoptosis. For this purpose, we co-cultured astrocytoma
cells (U251 and U87) with infected (CIB) or non-infected
T cell lines (CEM). After 3 h interaction, lymphocyte cell
lines were removed from the co-cultures through vigorous
cold PBS washings. Complete removal of T cell lines was
confirmed in paired co-cultures stained by Giemsa and
observed by light microscopy. The astrocytoma cells were
then kept in culture for up to 10 days with daily micro-
scopic observation. Figure 3 shows that 5 days after
lymphocyte removal, the astrocytoma cells exhibited im-
portant changes characterized by cell shrinkage, loss of
cell-cell contact, detachment from the monolayer and cell
death (Fig. 3c, f ).
These changes were further characterized by transmis-
sion electron microscopy (Fig. 3g–i). Astrocytoma cell
lines in the monolayers that have been transiently ex-
posed to HTLV-1 (but not to non-infected) T cell lines,
exhibited ultrastructural alterations, characterized bysevere cell shrinkage, loss of cell-cell contact (Fig. 3i)
and accumulation of secondary lysosomes (Fig. 3j).
These changes were evident as early as 3 days post
washing of T cell lines. In addition, virus-like particles
were observed within the cytoplasm of the astrocytoma
cells, suggesting that they become infected by HTLV-1
(Fig. 3j, i).
No morphological changes were observed in the mock
control (cultures of astrocytoma cells in absence of any
T lymphocyte cell lines, Fig. 3a, d and g) and the mono-
layer previously co-cultured with the non-infected CEM
T cell line (Fig. 3b, e, h), as ascertained by Giemsa stain-
ing and by electron microscopy. In order to control for
nonspecific effects of HTLV-1-infected T cell lines on as-
trocytoma cell lines, similar experiments were performed
using Hela cells, and no morphological alterations were
detected in these cells upon interactions with HTLV-1-
infected cell lines (Fig. 4).
Subsequent experiments were performed in order to
investigate if the cytopathic effect described above in-
volved increased apoptosis. We thus performed annexin
V plus propidium iodide staining (measured by cyto-
fluorometry) in astrocytoma cell lines after short-term
interaction with each T cell line. Figure 5 shows that tran-
sient contact with HTLV-1-infected T lymphocyte cell
lines resulted in enhanced annexin V labeling (as com-
pared to the values obtained with the non-infected T cell
Fig. 2 Co-culture of HTLV-1-infected T cell lines with astrocytoma cell lines result in rapid syncytium formation. HTLV-1-infected T cell lines (CIB and
C91PL) were co-cultured with astrocyte (U251 and U87) and non-astrocytic (Hela) cell lines for up to 20 h. After 20 h cells were fixed, stained with
Giemsa and observed on light microscopy. Syncytia were characterized by presence of large, irregular and multinucleated cells and were observed in
panels of co-culture of CIB with U251 (b–c) and U87 (f–g) and also in the panels of co-culture of C91PL with U251 (d), but not in the co-culture of
CEM (h) or CIB (i) with HeLa cell line. Original magnifications: ×200 (a–b, e–f and g–h) and × 400 (c–d and g)
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nated from necrotic cell death by the propidium iodide
staining profiles.Expression pattern of cell adhesion and migration-related
genes in astrocytoma cell lines following short-term incu-
bation with supernatants from HTLV-1+ T cell lines
Since soluble factors secreted by HTLV-1 infected T cell
lines, particularly soluble Tax1 protein, have been de-
scribed to exert paracrine effect on target cells [15], we
investigated whether supernatants from HTLV-1+ T cell
lines could affect the expression of cell adhesion and
migration-related genes on astrocytoma cell lines. In-
deed, transient exposure (30 min) to fractionated superna-
tants from the HTLV-1+ cell lines resulted in statistically
significant increase in the mRNA expression of various
cytokines/chemokines and adhesion molecules, including
the pro-inflammatory cytokine TNF-α, the TNF-α-
regulated chemokines CXCL1, CXCL2, CXCL3, CXCL8,
CCL2, IL13 and CXCL10, as well as V-CAM-1 and MMP-
8, as compared to the values obtained when theastrocytoma cells were subjected to supernatants from
non-infected T cell line cultures (Fig. 6).
Of note, although not statistically significant, qPCR
values for gene expression for various other chemo-
kines and ECM/adhesion molecules were slightly higher
(Additional file 1: Figure S1A–D and Additional file 2:
Figure S2A–D).
Enhanced migration of HTLV-1-infected T cell lines after
stimulation with supernatants from primed astrocytoma
cell lines
Considering that the expression pattern of various cell
migration-related genes was up-regulated in the astrocy-
toma cell lines cultured in presence of supernatants from
HTLV-1+ T cell lines, it was plausible to hypothesize that,
once astrocytes are primed by a first wave of infiltrating T
cells, they might play a role in the further recruitment of
T cells into the central nervous system. In order to address
this issue we applied supernatants from astrocytoma cell
cultures (U251) previously primed with a transient expos-
ure with the HTLV-1 infected (CIB) or non-infected
(CEM) T cell lines, as migratory stimuli for the migration
Fig. 3 Long-term cellular consequences on astrocytoma cell line monolayers following transient co-culture with HTLV-1-infected cell lines.
Long-term effects (5 days post co-culture) exerted by HTLV-1-infected T cell lines on astrocytes cell lines were assessed by co-culture of
astrocytoma cell lines (U251 and U87) with HTLV-1-infected (CIB) and non-infected (CEM) T cell lines. Astrocytoma cells were cultured only with
RPMI for mock control (a, d and g). Under light microscopy (magnifications = ×200), no morphological alterations were observed when CEM was
co-cultured with U251 (b) and U87 (e). Under light microscopy (magnifications = ×200), morphological alterations on astrocytoma cells were
characterized by presence of cell shrinkage, loss of cell-cell contact, seen when CIB cells was co-cultured with U251 (c) and U87 cell lines (f).
Under transmission electron microscopy, ultrastructural alterations were characterized not only by presence of cell shrinkage, loss of cell-cell
contact (i), but also accumulation of secondary lysosome (j), and presence of particles compatible with HTLV-1 virions (highlighted by arrows),
seen when U251 astrocytoma cells were co-cultured with CIB lymphocytes (j–l). No ultrastructural alteration were seen when U251 astrocytoma
cells were co-cultured with CEM (h)
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cells to supernatant of astrocytoma cell lines primed with
infected cell lines was significantly enhanced, as compared
to supernatants from untreated astrocytoma cell lines, or
those co-cultured with the non-infected T cell line (Fig. 7).
Discussion
The mechanisms underlying the pathogenesis of HAM/
TSP are still poorly understood. Although previous
evidence strongly suggests that astrocytes take part in
this process through several mechanisms [30–32], their
participation in the migration of T cells into the CNShas not been studied in deep. Given the central role of
astrocytes in the functional and structural homeostasis
of the CNS [28], any impairment of these cells would
potentially compromise CNS functional and structural
integrity. A better understanding of these processes is
thus essential for designing future effective therapeutic
and preventive strategies. In this context, we investi-
gated the effects exerted by HTLV-1 on astrocytes
using an in vitro model of heterocellular interaction
involving T cell lines and astrocytoma cell. Experimen-
tally, we used a T cell line derived from a HAM/TSP
patient (CIB), a T cell line originally infected by HTLV-
Fig. 4 Co-culture of HTLV-1-infected T cell lines with Hela cell line does not yield syncytium formation or morphological alterations. Exposure of Hela
cell lines to CEM (c–d) or CIB (e–f) cell lines does not lead to syncytium formation or morphological alterations. Upper panels show unstained cells
observed under optical microscopy and lower panels show Giemsa-stained cells. For Mock controls, cells were cultured with RPMI alone (a–b). Cells
cultures were maintained for up to 20 h. Original magnifications: ×200
Fig. 5 Enhancement of Annexin V binding to astrocytoma cell lines after transient interaction with the HTLV-1-infected T cell lines. Astrocytoma
cell lines (U251) were transiently co-cultured with HTLV-1-infected (CIB) and non-infected (CEM) T lymphocyte cell lines. For Mock control, U251
cell were cultured in presence of RPMI alone. Enhanced annexin V binding was observed when U251 was co-cultured with CIB (U215-CIB) as
compared to co-culture with CEM cell (U215-CEM) or Mock control (U215)
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Fig. 6 Modulation of cell adhesion and migration-related gene expression in astrocytoma cell lines after transient exposure to supernatants of
HTLV-1-infected T cell lines. Astrocytoma cell lines (U251) were primed with supernatants from CIB (Ast-CIB) and CEM (Ast-CEM) T cells cultures.
For Mock control, astrocytoma cells were treated with RPMI alone (Mock). After 1 h of exposure, cells were washed, harvested and RNA was
extracted. Ast-CIB expressed statistically significant higher amounts of RNA for all illustrated genes as compared to Ast-CEM and Mock. Data derive
from 3 independent experiments
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and U87).
We first demonstrated that HTLV-1-infected T cell
lines adhered significantly higher to the astrocytoma
monolayers as compared to the non-infected T cell line.
This finding suggests that astrocytes may represent acritical target of HTLV-1 infected lymphocytes. Previous
studies also demonstrated that HTLV-1 infected cell
lines adhered stronger to endothelial cell lines [35]. We
also observed that co-culture of astrocytoma cell lines
with HTLV-1 infected, (but not with non-infected) T cell
lines, resulted in rapid syncytium formation, seen as
Fig. 7 Enhanced migratory response of HTLV-1-infected T lymphocyte
cell lines treated with supernatants from astrocytoma cell lines primed
after transient interaction with HTLV-1-infected T cell lines. The HTLV-1-
infected T cell line (CIB) was allowed to migrate in transwell chambers
whose bottom wells contained supernatants from astrocytoma cell
cultures that were primed with HTLV-1-infected versus non-infected T
cell lines. Migrating cells, harvested in the lower chambers, were
counted using trypan blue cell viability analysis. Values correspond to
mean ± standard error of 3 independent experiments for each T cell
line. *p < 0.05
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was observed when a non-astrocyte cell line was used as
a control, demonstrating that this effect is at least to
some extent cell type specific. This result is in agree-
ment with previous observations, in which rapid syncyt-
ium formation was detected when HTLV-1 infected
lymphocyte cell lines were co-cultured with astrocyte
cell lines [32]. These findings allow us to hypothesize
that HTLV-1 infected cells have an increased ability to
cross the blood–brain barrier into the CNS, where they
rapidly and strongly bind to the astrocytoma, leading to
severe functional and morphological damage.
In a second set of experiments, we observed several and
extensive morphological changes and cytopathic effect in 5-
day culture of astrocytoma cell cultures that were transi-
ently exposed to HTLV-1-infected T cell lines, but not to
non-infected counterparts. The cytopathic effect was char-
acterized by loss of cell-cell contact, cell shrinkage, accumu-
lation of lysosomal vesicles and cell death. Notably, similar
morphological alterations have been observed in endothe-
lial cells after transient interaction with the MT-2 HTLV-1+
T cell line [35]. These alterations were rather cell type spe-
cific since co-culture of HTLV-1 infected T cell lines with
the Hela cell line, a non-astrocytic lineage, did not result in
any cytopathic effect (see Fig. 4). We also detected an en-
hancement of astrocytoma apoptosis secondary to the
interaction with HTLV-1-infected cells as shown in Fig. 5, a
finding corroborated by similar results previously reported
[36–38]. Several mechanisms has been proposed to explainthe apoptotic effect of HTLV-1 infected T cells on astro-
cytes, such as the direct effect of secreted Tax-1 protein in
inducing apoptotic pathways in the target cell through the
down regulation in the cellular expression of bcl-2 [36, 37]
and susceptibility of astrocytes to apoptosis secondary to
increase in the production of TNF-α [38].
Of note, we observed the presence of HTLV-1 viral
particles in the cytoplasm of astrocytoma cells after tran-
sient interaction with HTLV-1+ T cells line, but not with
the non-infected T cell line. Infection of astrocytes with
HTLV-1 has been reported in previous studies [39–41],
and suggests that direct infection may also be involved
in the functional and morphological damage of human
astrocytes in HAM/TSP.
We also investigated the role played by the soluble
factors secreted by HTLV-1+ T cell lines on cultured
astrocyte cell lines. We used qPCR arrays to quantita-
tively evaluate the expression levels of a large numbers
of cell migration-related genes, including cytokines/che-
mokines and extracellular matrix/cell adhesion proteins.
A short-term (1 h) exposure of astrocytoma cell lines to
fractionated HTLV-1-infected T cell lines-derived super-
natants, resulted in statistically significant increase in
the mRNA of TNF-α, various chemokines, as well as
VCAM-1 and MMP-8, as compared with supernatants
derived from the non-infected T cell line, as shown in
Fig. 6. These results strongly corroborate the findings re-
ported by Ando and cols. (2013), who found an in-
creased CXCL10 production by astrocytes that were
transiently co-cultured with CIB cells [42] and also with
results reported by Tomoo and cols. (2013), who found
that level of CXCL10 in the CSF correlated with progres-
sion to HAM/TSP [43], suggesting that CXCL10 might
play a critical role in stimulating migration of HTLV-1
infected T cells in the transwell chamber and ultimately
reflecting what happens in vivo, when T-cells migrate
into the CNS. Our results are also in line with previous
histopathological findings from post-mortem tissues, in
which it has been found that astrocytes from HAM/TSP
lesions exhibit higher contents of proinflammatory cyto-
kines, MMP and chemokines [14, 29, 30].
Moreover, our data corroborate those described by
Akaoka (2011) and Szymocha (2000), who demonstrated
that infiltrating HTLV-1-infected T lymphocytes in the
CNS continuously induce significant changes in astro-
cytes, not only through cell-cell interaction [44], but also
through soluble elements, particularly the 42 kDa Tax-1
viral protein [31]. Tax is a transactivator/oncoprotein
thought to play an important role in the course of
HAM/TSP, and soluble Tax1 has been shown to induce
functional changes in human astrocytes [36] and to
modulate gene expression on target cells [15].
Conjointly, these findings strongly point to an import-
ant paracrine effect of HTLV-1 infected lymphocytes on
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of astrocytes occurring in HAM/TSP, would be much
more complex than ever described.
Our findings suggest that the functional impairment of
astrocytes caused by interactions with HTLV-1-infected
T cells contributes to the perpetuation and amplification
of the CNS damage. Considering that we applied a 30–
50 kDa supernatant fraction to stimulate the astrocy-
toma cells, it is conceivable that Tax1 protein is involved
in these effects. Yet, additional studies with blocking
antibodies are required to confirm this hypothesis.
Since astrocytes primed with HTVL-1-infectd T cells
expressed higher levels of various cell adhesion and
migration-related mRNA molecules, it seemed plausible
to hypothesize that supernatants from such primary cul-
tures could enhance T cell migration. Actually, this was
the case and supernatants from HTLV-1 primed astrocy-
toma cell lines were able increase the migration of
HTLV-1 infected T cell lines. Conceptually, these data
suggest that activated astrocytes would enhance the re-
cruitment of additional T cells into the CNS. Since main
focus of this study was to understand the impact of a
HAM/TSP derived T cell line (CIB), the in vitro de-
rived HTLV-1 infected T cell line (C91PL) was used
as a control only in the first set of experiments when
we observed that the effects were similar when using
both cell lines.
Although we have not performed immune staining to
confirm the presence of HTLV-1 inside the cells, we be-
lieve that the viral particle detection by electron micros-
copy is a convincing evidence of astrocyte infection.
Similarly, we also think that the enhanced T cell migra-
tion after being primed by supernatants from infected
astrocytes suggests an increased concentration of
chemotactic factors, as indicated by the elevated expres-
sion of the corresponding mRNAs by HTLV-1-infected
astrocytes.
Of remark, our results are of utmost importance,
since most of the previous work that investigated
HTLV-1-induced changes on astrocytes used in vitro
derived HTLV-1-infected T cell lines, such as MT-2
or C91PL [29, 31–34, 45]. In our study we used a
HAM/TSP patient-derived lymphocyte T cell line. In-
deed, to our knowledge, only Ando and co-workers
conducted functional assays on astrocytes using same
cell line [42].Conclusion
In conclusion, our results show that HAM/TSP-de-
rived T lymphocyte cell lines exert a pleiotropic
effects upon astrocyte cell lines, leading to astrocyte
damage and increased secretion of attracting cyto-
kines, which in turn may participate in the furtherattraction of HTLV-1-infected T cells into central ner-
vous system (CNS), thus amplifying and prolonging
the immune damage of CNS.Methods
Cell lines
The human malignant astrocytoma cell lines U251 and
U87, both derived from malignant gliobastoma multi-
forme (gently provided by Dr Maria do Socorro Pombo
de Oliveira, National Cancer Institute, Rio de Janeiro)
[46], were grown in high glucose (4500 mg/l) Dulbecco
Modified Eagle Medium (DMEM; Gibco-BRL, Grand
Island, NY) supplemented with 10 % fetal calf serum
(FCS) (Cultilab, Campinas, Brasil), 2 mM L-glutamine
(Gibco, Scotland, UK), 100 U/ml penicillin and 100 g/
ml streptomycin (Gibco, Scotland, UK) at 37 °C in a
humidified incubator with 5 % CO2. Hela cells, an
epithelial cell line derived from cervical cancer cells
[47], were used as a negative control in some experi-
ments. The HTLV-1-infected T cell line CIB (gently
provided by Dr. Olivier Hermine, Necker Hospital,
Paris) was derived from a HAM/TSP patient [48].
The HTLV-1-infected T cell line C91PL was derived
from human cord blood T lymphocytes immortalized
by HTLV-I infection [49] (used in several assays as a
positive control and gently provided by Dr. Olivier
Hermine, Necker Hospital, Paris). The non-infected
T-cell line CEM, derived from a patient with acute
lymphoblastic leukemia, [50] (used as a negative con-
trol and gently provided by Dr Maria do Socorro
Pombo de Oliveira, National Cancer Institute, Rio de
Janeiro) was cultured in RPMI 1640 supplemented
with 10 % fetal calf serum, 100 U/ml penicillin and
100 g/ml streptomycin at 37 °C, 5 % CO2. Cultures
of the HTLV-1-infected T cell lines were further sup-
plemented with 100 U/ml of interleukin 2 (IL-2)
(Roche, France).Heterocellular adhesion assay
For adhesion assays, astrocytoma and Hela cells were
first plated in 25 cm2 flasks until sub-confluence.
Then, HTLV-1-infected or non-infected T lympho-
cytes were added to the astrocyte monolayer at a ra-
tio astrocyte: lymphocyte of 1:4 and allowed to
adhere for 30 min at 37 °C, 5 % CO2 in RPMI 1640
supplemented with 2 mM L-glutamine and antibiotics
in absence of FCS and IL-2. Supernatants containing
floating lymphocytes were then discarded and the
contents of each flask (astrocytes + adhered lympho-
cytes) were fixed in absolute ethanol, stained with
Giemsa and counted to determine the adhesion index
(AI), as previously described [51] and validated for
this type of analysis [52], using the following formula:
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Lymphocytes adhered to astrocytes
Total number of astrocytes
 100Assessment of syncytium formation
To assess syncytium formation, astrocytoma cells were
initially grown in 25 cm2 flasks until sub-confluence.
HTLV-1-infected T lymphocytes (CIB or C91PL) or the
non-infected T cell line (CEM) were added to the mono-
layer of astrocytoma at astrocyte/lymphocyte ratio of 1:4
and left to adhere for up to 20 h in culture conditions
similar to those described above. Supernatant was then
discarded, washed briefly with PBS, fixed in absolute
ethanol, stained with Giemsa and observed by light
microscopy. Similar assays were performed using a non-
astrocytic cell line (Hela), to assess whether changes
were specific for astrocytes.
Morphological assessment of cultured astrocytoma cells
Astrocytoma cells were initially grown in 25 cm2 flasks
until sub-confluence. Transient co-cultures of astrocytes
with either HTLV-1-infected T lymphocytes (CIB or
C91PL) or the non-infected T cell line (CEM) were per-
formed by replacing the medium in the astrocytoma cul-
tures with those from cultures of HTLV-1-infected or
non-infected T cell lines in the absence of IL-2 at 37 °C,
5 % CO2, at astrocyte/lymphocyte ratio of 1:4. After 3 h,
lymphocytes were completely removed from the cultures
by vigorous washing using cold PBS. Duration of co-
culture was set at 3 h, since the study conducted by
Mor-Vaknin et al., [32], demonstrated that syncytium
was formed as early as 4 h post co-culture and in our
experiments syncytium was formed as early as 6 h post
co-culture.
Hela cells were used as controls for nonspecific inter-
actions between astrocytes and HTLV-1-infected cells.
For Mock controls, astrocytes were culture alone with
RPMI.
After lymphocyte removal by vigorous washings with
cold PBS, astrocytoma and Hela cells were kept in cul-
ture for up to 5 days, replenishing fresh medium every
two days. At days 5 post co-culture, astrocytes were
processed for optical or transmission electron micros-
copy, as previously described [53], using current 2.5 %
glutaraldehyde 1 % paraformaldehyde fixation, followed
by uranyl acetate plus lead citrate staining, with the ana-
lysis of ultrathin sections being done under a transmis-
sion electron microscope (Jeol JEM-1011) on the Rudolf
Barth Electron Microscopy Platform at the Oswaldo
Cruz Institute (Fiocruz, Rio de Janeiro).Apoptosis of astrocytoma cells induced by HTLV-1-
infected lymphocytes
The ability of HTLV-1 or non-infected T cells to induce
apoptosis on the astrocytoma cells was measured by cyto-
fluorometry using FITC-coupled Annexin V Apoptosis De-
tection Kit I (Becton-Dickinson/Pharmingen, San Diego).
After transient co-cultures during 3 h, followed by lympho-
cyte removal by vigorous washings with cold PBS, astro-
cytes were kept in culture for additional 2 h, trypsinized
and stained with FITC-Annexin V and Propidium Iodide
according to the manufacturer’s instructions. Events were
acquired using a FACSCalibur Flow Cytometer (Becton-
Dickinson, San Diego, USA).
Cell adhesion and cell migration-related gene expression
of astrocytoma cells primed with supernatants from
HTLV-1-infected T lymphocytes
We further evaluated the effect exerted by HTLV-1-
infected cells on the expression of cell adhesion and cell
migration-related genes in astrocytoma cells. Astrocytes
were primed using supernatants from HTLV-1-infected
T cell cultures, using as control counterpart superna-
tants from non-infected T cell cultures. For this purpose,
lymphocytes were grown in 75 cm2 culture flasks at an
initial concentration of 1x107 cells/mL during 24hs.
Supernatants were then collected and concentrated
using the centripep YM-50 and YM-30 filters (Millipore,
corporation, County Cork, Ireland), according to the
manufacturer’s instructions. The fraction was added to
the astrocyte monolayer for 1 h at 37 °C and then, cells
were then trypsinized and washed. As a mock control,
growing astrocytes were treated with RPMI alone.
Total RNA was extracted using RNeasy Micro Kit
(Qiagen, Hilden, Germany), according to the manufac-
turers instructions, including DNAse treatment. Total
RNA was quantified by spectrophotometry using Nano-
drop 2000 (Thermo Scientific, USA). RNA integrity was
assessed for the presence of ribosomal RNA 28S and
18S, using denaturating agarose gel electrophoresis as
previously described [54]. RNA was used for the RT-
PCR if the ratio A260/A230 ≈ 2.0.
Gene expressing profiles for cytokines/chemokines
and extracellular matrix (ECM) proteins/adhesion mole-
cules were ascertained by quantitative PCR. cDNAs were
prepared from 1 μg RNA of each sample using “RT2
First Strand” (SABioscience, Maryland, USA), according
to the manufacturers instructions. Then, RT2 SYBR
Green/ROX PCR Master Mix (SABioscience) and’
nuclease-free water were added to the cDNA. Twenty-
five μL of this mixture were added to 96 microplates
containing primers for each of the 84 target genes for
ECM proteins/adhesion molecules using corresponding
qPCR arrays (SABioscience/Qiagen, USA), as seen in sup-
plementary data in S1 Table and S2 Table. Amplification
Gudo et al. Virology Journal  (2015) 12:165 Page 11 of 12signals were captured using the ABI Prism 7000 PCR de-
vice (Applied Biosystems, Foster City, CA, USA). Melting
curve analysis was performed for each sample at the end
of the PCR.
Migration profile of HTLV-1-T lymphocytes cell lines
under the stimulation of supernatants from primed astro-
cytoma cell lines
Cell migration studies were conducted in transwell
chambers (Corning Costar, Cambridge, MA, USA), as
described elsewhere [55], using the 8-μm pore size
inserts coated with 10 μg/ml of BSA, for 1 h at 37 °C.
Supernatants from astrocytoma cultures previously
primed with HTLV-1-T cell lines (3 h co-culture) were
harvested and added into the lower chamber, whereas
106 CIB cells/100 μl (of RPMI/1 % BSA) were added
into the upper chambers. After 4 h incubation at 37 °C
in 5 % CO2, we counted the cells that migrated into the
lower chambers using trypan blue cell viability analysis.
Statistical analysis
All statistical analyses were performed using the Graph-
Pad Prism 5.01 software package. Quantitative data were
expressed as the mean ± standard error. The Student’s t-
test and the One Way ANOVA test were used to compare
the differences among groups. Differences were consid-
ered statistically significant when the p values were ≤ 0.05.
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Additional file 1: Figure S1. Cytokine/Chemokine gene expression in
astrocytoma cell line after transient exposure to supernatants of HTLV-1-
infected T cell lines. The astrocyte cell line (U251) was primed with
supernatants from cultured CIB (Ast-CIB) and CEM (Ast-CEM) T cells. For
Mock control, astrocytoma cells were treated with RPMI alone (Mock).
After 1 h of exposure, cells were washed, harvested and RNA was
extracted. Ast-CIB expressed statistically significant higher amounts of RNA
for all illustrated genes as compared to Ast-CEM and Mock. Data derive from
3 independent experiments. (PDF 614 kb)
Additional file 2: Figure S2. Extracellular matrix proteins gene
expression in astrocytoma cell lines after transient exposure to
supernatants of HTLV-1-infected T cell lines. The astrocytoma (U251) were
primed with supernatants from cultured CIB (Ast-CIB) and CEM (Ast-CEM)
T cell lines. For Mock control, astrocytoma cells were treated with RPMI
alone (Mock). After 1 h of exposure, cells were washed, harvested and
RNA was extracted. Ast-CIB expressed statistically significant higher
amounts of RNA for all illustrated genes as compared to Ast-CEM and
Mock. Data derive from 3 independent experiments. (PDF 592 kb)
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